Specialty Pharma Journal Specialty, Precision & Technology
(Boston)–Researchers have identified two new genetic risk factors for Alzheimer’s disease (AD) among African Americans. The findings, which appear online in the journal Alzheimer’s and Dementia, may lead to the development of new therapies specifically targeting those genes. Despite the fact that AD is more common in African Americans than …
Tag Archives: gene targeting
October, 2016
March, 2015
-
12 March
Genetic Test Maker 23andMe Hires Biotech Executive to Lead its Drug Development Effort
Google-backed genetic-testing company 23andMe is launching its own drug development unit, and bringing on former Genentech executive to become its chief scientist and lead the company’s research and development efforts. 23andMe has collected genetic information from more than 850,000 customers worldwide from its $99 DNA spit test and more than …
-
4 March
Gene Mutation May Predict Immunotherapy Outcome in Melanoma Patients
Melanoma patients whose tumors had a specific gene mutation demonstrated better response and treatment outcomes when treated with immunotherapies, according to a new study. Researchers found that among melanoma patients who were treated with immunotherapies, individuals whose tumors had mutations in the NRAS gene responded better to treatment compared to …